Published

  1. Hazlett, L. D. and R. L. Hendricks. 2010. Reviews for immune privilege in the year 2010: immune privilege and infection. Ocul.Immunol.Inflamm. 18:237-243.
  2. Ramachandran, S., K. A. Davoli, M. B. Yee, R. L. Hendricks, and P. R. Kinchington. 2010. Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion. J.Virol. 84:8811-8820.
  3. Knickelbein, J. E., S. C. Watkins, P. G. McMenamin, and R. L. Hendricks. 2009. Stratification of Antigen-presenting Cells within the Normal Cornea. Ophthalmol.Eye Dis. 1:45-54.
  4. Frank, G. M., S. J. Divito, D. M. Maker, M. Xu, and R. L. Hendricks. 2010. A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis. Invest Ophthalmol.Vis.Sci. 51:3591-3598.
  5. Frank, G. M., A. J. Lepisto, M. L. Freeman, B. S. Sheridan, T. L. Cherpes, and R. L. Hendricks. 2010. Early CD4(+) T cell help prevents partial CD8(+) T cell exhaustion and promotes maintenance of Herpes Simplex Virus 1 latency. J.Immunol. 184:277-286.
  6. Vicetti Miguel, R. D., B. S. Sheridan, S. A. Harvey, R. S. Schreiner, R. L. Hendricks, and T. L. Cherpes. 2010. 17-beta estradiol promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent. J.Virol. 84:565-572.
  7. Knickelbein, J. E., R. L. Hendricks, and P. Charukamnoetkanok. 2009. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv.Ophthalmol. 54:226-234.
  8. Sheridan, B. S., T. L. Cherpes, J. Urban, P. Kalinski, and R. L. Hendricks. 2009. Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes. J.Virol. 83:2237-2245.
  9. Knickelbein, J. E., K. M. Khanna, M. B. Yee, C. J. Baty, P. R. Kinchington, and R. L. Hendricks. 2008. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322:268-271.
  10. Ramachandran, S., J. E. Knickelbein, C. Ferko, R. L. Hendricks, and P. R. Kinchington. 2008. Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters. Virology 378:254-264.
  11. Cherpes, T. L., J. L. Busch, B. S. Sheridan, S. A. Harvey, and R. L. Hendricks. 2008. Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation. J.Immunol. 181:969-975.
  12. Divito, S. J. and R. L. Hendricks. 2008. Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest Ophthalmol.Vis.Sci. 49:1488-1495.
  13. Nakamura, Y., P. Watchmaker, J. Urban, B. Sheridan, A. Giermasz, F. Nishimura, K. Sasaki, R. Cumberland, R. Muthuswamy, R. B. Mailliard, A. T. Larregina, L. D. Falo, W. Gooding, W. J. Storkus, H. Okada, R. L. Hendricks, and P. Kalinski. 2007. Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity. Cancer Res. 67:10012-10018.
  14. Sheridan, B. S., J. E. Knickelbein, and R. L. Hendricks. 2007. CD8 T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia. Expert Opin.Biol.Ther. 7:1323-1331.
  15. Freeman, M. L., B. S. Sheridan, R. H. Bonneau, and R. L. Hendricks. 2007. Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections. J.Immunol. 179:322-328.
  16. Knickelbein, J. E., S. Divito, and R. L. Hendricks. 2007. Modulation of CD8+ CTL effector function by fibroblasts derived from the immunoprivileged cornea. Invest Ophthalmol.Vis.Sci. 48:2194-2202.
  17. Divito, S., T. L. Cherpes, and R. L. Hendricks. 2006. A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol.Res. 36:119-126.
  18. Lepisto, A. J., G. M. Frank, and R. L. Hendricks. 2007. How herpes simplex virus type 1 rescinds corneal privilege. Chem.Immunol.Allergy 92:203-212.
  19. Lepisto, A. J., M. Xu, H. Yagita, A. D. Weinberg, and R. L. Hendricks. 2007. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis. J.Leukoc.Biol. 81:766-774.
  20. Sheridan, B. S., K. M. Khanna, G. M. Frank, and R. L. Hendricks. 2006. Latent virus influences the generation and maintenance of CD8+ T cell memory. J.Immunol. 177:8356-8364.
  21. Lepisto, A. J., G. M. Frank, M. Xu, P. M. Stuart, and R. L. Hendricks. 2006. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice. Invest Ophthalmol.Vis.Sci. 47:3400-3409.
  22. Hendricks, R. L. 2006. Interaction of angiogenic and immune mechanisms in the eye. Semin.Ophthalmol. 21:37-40.
  23. Prabhakaran, K., B. S. Sheridan, P. R. Kinchington, K. M. Khanna, V. Decman, K. Lathrop, and R. L. Hendricks. 2005. Sensory neurons regulate the effector functions of CD8+ T cells in controlling HSV-1 latency ex vivo. Immunity 23:515-525.
  24. Decman, V., M. L. Freeman, P. R. Kinchington, and R. L. Hendricks. 2005. Immune control of HSV-1 latency. Viral Immunol. 18:466-473.
  25. Decman, V., P. R. Kinchington, S. A. Harvey, and R. L. Hendricks. 2005. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J.Virol. 79:10339-10347.
  26. Khanna, K. M., A. J. Lepisto, V. Decman, and R. L. Hendricks. 2004. Immune control of herpes simplex virus during latency. Curr.Opin.Immunol. 16:463-469.
  27. Xu, M., A. J. Lepisto, and R. L. Hendricks. 2004. CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas. J.Immunol. 173:1232-1239.
  28. Khanna, K. M., A. J. Lepisto, and R. L. Hendricks. 2004. Immunity to latent viral infection: many skirmishes but few fatalities. Trends Immunol. 25:230-234.
  29. Khanna, K. M., R. H. Bonneau, P. R. Kinchington, and R. L. Hendricks. 2003. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18:593-603.
  30. Xu, M., A. J. Lepisto, and R. L. Hendricks. 2002. Co-stimulatory requirements of effector T cells at inflammatory sites. DNA Cell Biol. 21:461-465.
  31. Brissette-Storkus, C. S., S. M. Reynolds, A. J. Lepisto, and R. L. Hendricks. 2002. Identification of a novel macrophage population in the normal mouse corneal stroma. Invest Ophthalmol.Vis.Sci. 43:2264-2271.
  32. Liu, T., K. M. Khanna, B. N. Carriere, and R. L. Hendricks. 2001. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J.Virol. 75:11178-11184.
  33. Liu, T., K. M. Khanna, X. Chen, D. J. Fink, and R. L. Hendricks. 2000. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J.Exp.Med. 191:1459-1466.
  34. Hendricks, R. L. 1999. Immunopathogenesis of viral ocular infections. Chem.Immunol. 73:120-136.
  35. Kodukula, P., T. Liu, N. V. Rooijen, M. J. Jager, and R. L. Hendricks. 1999. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J.Immunol. 162:2895-2905.
  36. Epstein, R. J., R. L. Hendricks, and R. M. Lipman. 1999. Cyclosporine and neovascularization. Ophthalmology 106:3-4.
  37. Chen, H. and R. L. Hendricks. 1998. B7 costimulatory requirements of T cells at an inflammatory site. J.Immunol. 160:5045-5052.
  38. Goldsmith, K., W. Chen, D. C. Johnson, and R. L. Hendricks. 1998. Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J.Exp.Med. 187:341-348.
  39. Hendricks, R. L. 1997. An immunologist's view of herpes simplex keratitis: Thygeson Lecture 1996, presented at the Ocular Microbiology and Immunology Group meeting, October 26, 1996. Cornea 16:503-506.
  40. Sciammas, R., P. Kodukula, Q. Tang, R. L. Hendricks, and J. A. Bluestone. 1997. T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J.Exp.Med. 185:1969-1975.
  41. Tang, Q., W. Chen, and R. L. Hendricks. 1997. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J.Immunol. 158:1275-1283.
  42. Tang, Q. and R. L. Hendricks. 1996. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J.Exp.Med. 184:1435-1447.
  43. Chen, W., Q. Tang, and R. L. Hendricks. 1996. Ex vivo model of leukocyte migration into herpes simplex virus-infected mouse corneas. J.Leukoc.Biol. 60:167-173.
  44. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J.Virol. 70:264-271.
  45. Dennis, R. F., K. F. Siemasko, Q. Tang, R. L. Hendricks, and A. Finnegan. 1995. Involvement of LFA-1 and ICAM-1 in the herpetic disease resulting from HSV-1 corneal infection. Curr.Eye Res. 14:55-62.
  46. Siegfried, C. J. and R. L. Hendricks. 1994. Melanin can deplete immunosuppressive substances from the aqueous humor. Curr.Eye Res. 13:869-873.
  47. Goins, W. F., L. R. Sternberg, K. D. Croen, P. R. Krause, R. L. Hendricks, D. J. Fink, S. E. Straus, M. Levine, and J. C. Glorioso. 1994. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J.Virol. 68:2239-2252.
  48. Dingwell, K. S., C. R. Brunetti, R. L. Hendricks, Q. Tang, M. Tang, A. J. Rainbow, and D. C. Johnson. 1994. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J.Virol. 68:834-845.
  49. Hendricks, R. L., T. M. Tumpey, and A. Finnegan. 1992. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J.Immunol. 149:3023-3028.
  50. Hendricks, R. L., M. Janowicz, and T. M. Tumpey. 1992. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J.Immunol. 148:2522-2529.
  51. Lipman, R. M., R. J. Epstein, and R. L. Hendricks. 1992. Suppression of corneal neovascularization with cyclosporine. Arch.Ophthalmol. 110:405-407.
  52. Kaya, M., D. P. Edward, H. Tessler, and R. L. Hendricks. 1992. Augmentation of intraocular inflammation by melanin. Invest Ophthalmol.Vis.Sci. 33:522-531.
  53. Begley, C. G., B. Y. Yue, and R. L. Hendricks. 1991. Murine trabecular meshwork cells in tissue culture. Curr.Eye Res. 10:1015-1030.
  54. Epstein, R. J., R. L. Hendricks, and D. M. Harris. 1991. Photodynamic therapy for corneal neovascularization. Cornea 10:424-432.
  55. Hendricks, R. L., P. C. Weber, J. L. Taylor, A. Koumbis, T. M. Tumpey, and J. C. Glorioso. 1991. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. J.Gen.Virol. 72 ( Pt 7):1601-1610.
  56. Hendricks, R. L., R. J. Epstein, M. A. Viana, and D. A. Hoffmann. 1991. A reproducible method for injecting the mouse corneal stroma. Invest Ophthalmol.Vis.Sci. 32:366-370.
  57. Hendricks, R. L. and T. M. Tumpey. 1991. Concurrent regeneration of T lymphocytes and susceptibility to HSV-1 corneal stromal disease. Curr.Eye Res. 10 Suppl:47-53.
  58. Hendricks, R. L. and T. M. Tumpey. 1990. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Invest Ophthalmol.Vis.Sci. 31:1929-1939.
  59. Epstein, R. J., R. L. Hendricks, and R. D. Stulting. 1990. Interleukin-2 induces corneal neovascularization in A/J mice. Cornea 9:318-323.
  60. Hendricks, R. L., C. F. Barfknecht, R. D. Schoenwald, R. J. Epstein, and J. Sugar. 1990. The effect of flurbiprofen on herpes simplex virus type 1 stromal keratitis in mice. Invest Ophthalmol.Vis.Sci. 31:1503-1511.
  61. Bartik, M. M., M. C. Ahn, B. A. Baumgartel, R. L. Hendricks, and M. B. Mokyr. 1990. Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy. Cancer Immunol.Immunother. 32:143-153.
  62. Hendricks, R. L., T. R. Malek, and B. Y. Yue. 1990. Expression of a p55 interleukin-2 receptor-like molecule on corneal epithelial cells. Reg Immunol. 3:29-34.
  63. Young, T. L., J. B. Robin, G. N. Holland, R. L. Hendricks, J. F. Paschal, R. E. Engstrom, Jr., and J. Sugar. 1989. Herpes simplex keratitis in patients with acquired immune deficiency syndrome. Ophthalmology 96:1476-1479.
  64. Brodsky, A. E., R. L. Hendricks, M. A. Khalil, B. V. Darden, and T. T. Brotzman. 1989. Segmental ("floating") lumbar spine fusions. Spine (Phila Pa 1976.) 14:447-450.
  65. Hendricks, R. L., M. S. Tao, and J. C. Glorioso. 1989. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis. J.Immunol. 142:263-269.
  66. Hendricks, R. L., R. J. Epstein, and T. Tumpey. 1989. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Invest Ophthalmol.Vis.Sci. 30:105-115.
  67. Hendricks, R. L. and G. A. Fishman. 1987. Interferon-gamma production and HLA-DR expression in patients with retinitis pigmentosa. Exp.Eye Res. 45:923-931.
  68. Ksander, B. R. and R. L. Hendricks. 1987. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Invest Ophthalmol.Vis.Sci. 28:1986-1993.
  69. Epstein, R. J., R. D. Stulting, R. L. Hendricks, and D. M. Harris. 1987. Corneal neovascularization. Pathogenesis and inhibition. Cornea 6:250-257.
  70. Hendricks, R. L. and G. A. Fishman. 1986. Cellular immune function of patients with retinitis pigmentosa. Invest Ophthalmol.Vis.Sci. 27:356-363.
  71. Hendricks, R. L. and J. Sugar. 1985. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population. Invest Ophthalmol.Vis.Sci. 26:208-213.
  72. Hendricks, R. L. and J. Sugar. 1985. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity. Invest Ophthalmol.Vis.Sci. 26:201-207.
  73. Hendricks, R. L. and G. A. Fishman. 1985. Lymphocyte subpopulations and S-antigen reactivity in retinitis pigmentosa. Arch.Ophthalmol. 103:61-65.
  74. Hendricks, R. L. and J. Sugar. 1984. Lysis of herpes simplex virus (HSV) infected targets. I. A comparison of the activity of lymphocytes from patients with HSV recurrences at different anatomical sites. Curr.Eye Res. 3:473-480.
  75. Hendricks, R. L. and J. Sugar. 1984. Lysis of herpes simplex virus-infected targets. II. Nature of the effector cells. Cell Immunol. 83:262-270.
  76. Loren, A. B., R. L. Hendricks, and M. M. Yokoyama. 1978. Anti-kappa/lambda immunobead for detection of human B lymphocytes. Immunol.Commun. 7:691-699.